ZURA: Zura Bio Limited
Performance
ZURA -66.21%
Watchlist
Select an item
Summary
ZURA at a glance
ZURA returned -66.21% over the past year. Its worst drop in that year was -82.39%, smaller than 1% of stocks on Redstone, and its Sharpe ratio of -0.27 beats 17% of stocks on Redstone. It pays no dividends.
Current Drawdown
-82.39%
Rolling Volatility
264.97%
Actions
Metrics
Risk Indicators
Alpha-35.74%
Beta0.65x
Sharpe-0.27
Sortino-0.33
Omega0.94
Calmar-0.80
Martin-1.08
Profile
About ZURA
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $119M
- Listed
- Mar 2023
- Employees
- 40
- Headquarters
- La Jolla, CA
- Website
- zurabio.com
Comparisons